Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
Launched by AL-MUSTANSIRIYAH UNIVERSITY · Mar 16, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special mouthwash containing resveratrol, a natural antioxidant, on bad breath (halitosis) and gum health in dental students. The goal is to see if using this mouthwash can reduce bacteria that cause bad breath and improve gum conditions over a week. The trial focuses on undergraduate students at Mustansiriyah University and Wasit University who have gingivitis, a condition that can lead to swollen and bleeding gums.
To participate, students need to be between 20 and 23 years old, have at least 20 teeth, and show signs of bad breath related to gingivitis. They should not have used any mouthwash or dental treatments in the past week and must be free from certain health conditions and habits, such as smoking or drinking alcohol. If eligible, participants will use the mouthwash for seven days and help researchers understand its effectiveness in improving oral health and reducing bad breath.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Organoleptic tongue of scores \> 2 using (0-5scale) (Rosenberg and McCulloch, 1992)
- • Male and female undergraduate dental students without chemical plaque control measures for at least one weak
- • Male and female students with halitosis due to gingivitis
- • The age of students ranges from 20 to 23 years.
- • No periodontal treatment for at least one month
- • No systemic disease
- • No tobacco smoking
- • The patients must have at least 20 teeth
- Exclusion Criteria:
- • Smokers and alcoholics
- • Patient with periodontitis or pocket depth \> 6mm
- • Patient with orthodontics appliance
- • Open carious lesions, pericoronitis, dry socket, and fistula.
- • Patients with systemic disease and condition
- • taking medication in the last two weeks
- • Take garlic, onion, or licorice in the last 24 hours
- • using oral hygiene products in the last 24 hours
- • pregnant women
- • sinusitis, tonsilitis, and upper respiratory tract infection
About Al Mustansiriyah University
Al-Mustansiriyah University is a prominent academic institution located in Baghdad, Iraq, dedicated to advancing education, research, and healthcare. As a clinical trial sponsor, the university leverages its expertise in medical and scientific research to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodologies, Al-Mustansiriyah University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and reliability of its clinical trials, ultimately striving to enhance public health and advance medical practices within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Bab Al Moadham, Iraq
Patients applied
Trial Officials
NOOR AA TAHER, B.D.S
Principal Investigator
Al-Mustansiriyah University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported